Human Trails Of Israel's COVID-19 Vaccine 'Brilife' To Begin Soon

Israel has announced it will begin human trails of its COVID-19 vaccine, named 'Brilife', by the end of the October. Reportedly, the vaccine was developed in August, and now will go through the regulatory processes. It is being developed by the Israel Institute of Biological Research (IIRB). However, it has not been communicated that by when the trials will be concluded or when the vaccine would be available for use.